List of Versacloz drug patents

Versacloz is owned by Tasman Pharma.

Versacloz contains Clozapine.

Versacloz has a total of 1 drug patent out of which 0 drug patents have expired.

Versacloz was authorised for market use on 06 February, 2013.

Versacloz is available in suspension;oral dosage forms.

The generics of Versacloz are possible to be released after 01 May, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8057811 TASMAN PHARMA Stable clozapine suspension formulation
May, 2028

(5 years from now)

Drugs and Companies using CLOZAPINE ingredient

Market Authorisation Date: 06 February, 2013

Treatment: NA

Dosage: SUSPENSION;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic